Pfizer Declares A 20-Cent Fourth-Quarter 2011 Dividend

NEW YORK--(BUSINESS WIRE)-- The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 20-cent fourth-quarter 2011 dividend on the company’s common stock, payable December 6, 2011, to shareholders of record at the close of business on November 11, 2011.

The fourth-quarter 2011 cash dividend will be the 292nd consecutive quarterly dividend paid by Pfizer.



CONTACT:

Pfizer Inc.

Joan Campion (media)
212-733-2798
Suzanne Harnett (investors)
212-733-8009

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Other Health

MEDIA:

Logo
 Logo

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.